Literature DB >> 26424749

The NC11 domain of human collagen XVI induces vasculogenic mimicry in oral squamous cell carcinoma cells.

Konstanze B Bedal1, Susanne Grässel2, Gerrit Spanier3, Torsten E Reichert3, Richard J Bauer4.   

Abstract

Collagen XVI, a fibril-associated collagen with interrupted triple helix (FACIT) collagen, is involved in oral squamous cell carcinoma (OSCC) and glioblastoma progression. The NC11 domain of collagen XVI has been described previously with a strong implication in physiological processes. We detected the non-collagenous (NC) 11-domain in supernatants of OSCC cells after recombinant expression of full-length collagen XVI and in sera from OSCC patients and healthy individuals. Stable expression of NC11-green fluorescent protein (GFP) fusion protein in OSCC cells initiated proliferation control and block of anchorage-independent growth. Moreover, the NC11 domain triggered the generation of tubular-like net structures on laminin-rich matrix in contrast to mock-GFP control cells and cells expressing full-length collagen XVI. Taqman® quantitative PCR and diaminobenzidine staining in 2D- and 3D cell culture revealed a significantly increased gene and protein expression of VEGFR1, VEGFR2 and uPAR in recombinant NC11-GFP-expressing cells. Specific VEGF receptor inhibition with Axitinib or fetal calf serum heat inactivation prevented formation of tubular-like net structures. Accordantly, NC11-GFP coated culture slides led to an increase of focal adhesion contact formation and the upregulation of VEGFR1 and uPAR in three different non-transfected OSCC cell lines. In summary, we suggest that the NC11 domain of collagen XVI is a potential biomarker for OSCC and triggers vasculogenic mimicry via upregulation of endothelial receptors VEGFR1, VEGFR2 and uPAR in 2D- and 3D OSCC cell culture conditions.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26424749     DOI: 10.1093/carcin/bgv141

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

2.  Vasculogenic Mimicry-An Overview.

Authors:  Emily Marques Dos Reis; Fernanda Vieira Berti
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

4.  Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Pradip K Majumder; Biswanath Majumder; Nabendu Murmu
Journal:  J Cell Commun Signal       Date:  2022-09-05       Impact factor: 5.908

5.  RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.

Authors:  Kailiang Qiao; Yantao Liu; Zheng Xu; Haohao Zhang; Heng Zhang; Chao Zhang; Zhi Chang; Xinyan Lu; Zhongwei Li; Ce Luo; Yanrong Liu; Cheng Yang; Tao Sun
Journal:  Angiogenesis       Date:  2020-09-13       Impact factor: 10.658

Review 6.  Vasculogenic Mimicry: Become an Endothelial Cell "But Not So Much".

Authors:  Mónica Fernández-Cortés; Daniel Delgado-Bellido; F Javier Oliver
Journal:  Front Oncol       Date:  2019-08-22       Impact factor: 6.244

Review 7.  Vasculogenic Mimicry in Head and Neck Squamous Cell Carcinoma-Time to Take Notice.

Authors:  Abdelhakim Salem; Tuula Salo
Journal:  Front Oral Health       Date:  2021-03-31

8.  uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells.

Authors:  Elena Andreucci; Anna Laurenzana; Silvia Peppicelli; Alessio Biagioni; Francesca Margheri; Jessica Ruzzolini; Francesca Bianchini; Gabriella Fibbi; Mario Del Rosso; Chiara Nediani; Simona Serrat; Livia Fucci; Michele Guida; Lido Calorini
Journal:  Oncol Res       Date:  2021-07-27       Impact factor: 5.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.